Rat Bone Marrow Mesenchymal Stem Cell Differentiation to Insulin Producing Cells and Evaluation their Responses in Vitro and in Vivo

نویسندگان

  • Ahmad Ghorbani Department of Pharmacology, Pharmacological Research Center of Medicinal Plants, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad, Iran.
  • Reza Shafiee-Nick Department of Pharmacology, Pharmacological Research Center of Medicinal Plants, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad, Iran.
  • Seyyed Abbas Zojaj Department of Pharmacology, Pharmacological Research Center of Medicinal Plants, Faculty of Medicine, Mashhad University of Medical Sciences Mashhad, Iran.
چکیده

Background  In recent years, many researchers haveattempted to cure diabetes by using stem cells technology. Stem cells from different sources have capabilityto differentiateinto insulin producing cells (IPCs) by different methods. The obstaclesof these methods aretheirexpensive materials and complexity ofmethodswhichare practicallydisadvantagesfor producing enough transplantableIPCs that can cure a diabetic patient. The aim of present study was to test a method for isolation and differentiation of rat bone marrow mesenchymal stem cells (BMSC)into IPCs which is simple method and produce abundant IPCs. Methods: Adult male Wistar rats 4-6 weeks age and 200-250 g weight were used. Bone marrow was isolated from femoral bone under asepticconditionand cultured as monolayerin DMEM in a density of 1×106/well at 37ºC and 5% CO2 for72 h. After three passages, the cells were differentiated into adiposities and osteocyte cells which approved using oil red and alizarin red staining, respectively. To produce IPCs, BMSC was cultured in low glucose DMEM, with 1% DMSO and without FBS for three days on collagenated coverslips. After three days, theculture medium was changedto DMEM containing 25 mM glucose plus10%FBS and incubated for 7 days. For assessment of insulin secretion capabilityof IPCs, the cells were incubated in DMEM containing5.5 or 25 mM glucose with or without IBMX for two hours. Samples from the medium were taken for subsequent insulin assay For in vivo assay, the mice were made diabetic by injection 200 mg/kgstreptozocinintraperitoneally,which produced a fasting blood sugar about 450 mg/dl. For each mouse, 105 IPCs were injectedintraperitonally. Control mice were injected with 100 µl normal saline.The mice blood sugars were checked every 3 days with a glocoumeter device.  Results: The content of secreted insulin in 5.5 m M glucose concentration was about 40miu/ml that raised to72 miu/ml with incubation with 25 mM glucose. The insulin secretion was potentiated by IBMX which increased to 104miu/ml. One week after IPC transplantation to diabetic mice, fasting blood sugar was started to decrease. After two weeks of transplantation, the blood glucose was fallen to 265 mg/dL comparing to control mice which their fasting blood sugar was about 450 mg/dl until end of study. Conclusion: In this study we introduced a simple, valuable and low cost method to produce insulin producing cells from bone marrow mesenchymal stem cells which could be translated into human clinical trials. Keywords: Mesenchymal stem cells, Transplantation, Diabetes.

برای دانلود باید عضویت طلایی داشته باشید

برای دسترسی به متن کامل این مقاله و 10 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

rat bone marrow mesenchymal stem cell differentiation to insulin producing cells and evaluation their responses in vitro and in vivo

background  in recent years, many researchers haveattempted to cure diabetes by using stem cells technology. stem cells from different sources have capabilityto differentiateinto insulin producing cells (ipcs) by different methods. the obstaclesof these methods aretheirexpensive materials and complexity ofmethodswhichare practicallydisadvantagesfor producing enough transplantableipcs that can c...

متن کامل

In-vitro Differentiation of Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells to Insulin-Producing Cells

  Background & Objective: Diabetes is a major chronic metabolic disease in the world. Islet transplantation is a way to treat diabetes. Unfortunately, this method is restricted due to graft rejection and lack of donor islets. Mesenchymal Stem Cells (MSCS) have the ability to differentiate into Insulin-Producing Cells (IPCs). In this study, Human Umbilical Mesenchymal Stem Cells (HUMSCS) were in...

متن کامل

Differentiation Potential of Nestin (+) and Nestin (-) Cells Derived from Human Bone Marrow Mesenchymal Stem Cells into Functional Insulin Producing Cells

The feasibility of isolating and manipulating mesenchymal stem cells (MSCs) from human patients provides hope for curing numerous disease and disorders. Recent phenotypic analysis showed heterogeneity of MSCs. A nestin progenitor cell is a subpopulation within MSCs which plays a role in pancreas regeneration during embryogenesis. This study aimed to separate nestin (+) cells from human bone mar...

متن کامل

Harvesting of bone marrow mesenchymal stem cells from live rats and the in vitro differentiation of bone marrow mesenchymal stem cells into neuron-like cells

In the bone marrow, there are certain populations of stem cell sources with the capacity to differentiate into several different types of cells. Ideally, cell transplants would be readily obtainable, easy to expand and bank, and capable of surviving for sufficient periods of time. Bone marrow mesenchymal stem cells (BM-MSCs) possess all of these characteristics. One of the most important benefi...

متن کامل

Osteogenic Differentiation of Mesenchymal Stem Cells Via Osteoblast- Imprinted Substrate: In Vitro and In Vivo Evaluation in Rat Model

BACKGROUND: Stem cells have great effects in clinical cell-based therapy. Accordingly, controlling the behavior and directing the fate of stem cells cultured in the laboratory is an important issue. OBJECTIVES: The aim of this study was to evaluate osteogenic properties of adipose derived mesenchymal stem cells (ADSCs) which differentiated toward osteogenic linage by osteoblast-imprinted substr...

متن کامل

Ex vivo Expansion and Differentiation of Mesenchymal Stem Cells from Goat Bone Marrow

Objective(s) Mesenchymal stem cells (MSCs) from large animals as goat which is genetically more closely related to human have rarely been gained attentions. The present study tried to isolate and characterize MSCs from goat bone marrow. Materials and Methods Fibroblastic cells appeared in goat marrow cell culture were expanded through several subcultures. Passaged-3 cells were then different...

متن کامل

ذخیره در منابع من

ذخیره در منابع من ذخیره شده در منابع من

{@ msg_add @}

  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی راحت تر خواهید کرد

دانلود متن کامل

برای دسترسی به متن کامل این مقاله و 10 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید


عنوان ژورنال:

دوره 2  شماره 2.3

صفحات  64- 64

تاریخ انتشار 2014-05-01

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2021